The Beyond Tomorrow Podcast with Julian Issa

What if the Singularity isn’t coming but already here?

This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow

AI is accelerating breakthroughs across science, medicine, and technology at a pace once considered impossible. Peter Diamandis believes the next 5–10 years could redefine what humanity can achieve.

Yet AI’s promise is competing with fear, disruption, and dystopian narratives. The challenge is not only building the future, but shaping how people imagine it.

For Peter Diamandis, the answer is actionable optimism: identify the risks, believe they can be solved, and pursue the biggest moonshots. Longevity, education, and space could become the foundations of a radically different future.

Peter Diamandis is an entrepreneur, physician, and founder of XPRIZE and Singularity University. He is a leading advocate for moonshot thinking and breakthrough technologies.

⏱ Timestamps
00:00 Intro
00:10 The Blinding Speed of Change
02:06 A Future Where Anything Is Possible
04:06 Why Is the West Afraid of AI?
08:39 Why Fear AI?
10:23 AGI Is Already Here
11:37 Blind Optimism vs. Actionable Optimism
13:01 The Next Great Moonshot
14:01 The Rise of an Alien-Looking Economy
15:10 Who Will Win the XPRIZE?
15:46 If Tomorrow Was Your Last Day...

Connect with Peter: 
Website: https://www.diamandis.com/ 
Facebook: https://www.facebook.com/PeterDiamandis/
LinkedIn: https://www.linkedin.com/in/peterdiamandis/
Instagram: https://www.instagram.com/peterdiamandis
X: https://x.com/peterdiamandis
YouTube: https://www.youtube.com/@peterdiamandis 

Connect with Julian
Instagram: https://www.instagram.com/thebeyondtomorrowpodcast/  
Instagram: https://www.instagram.com/juliankissa/  
LinkedIn: https://uk.linkedin.com/in/julian-issa  
Website: www.beyondtomorrowpodcast.com 
Email: bookings@beyondtomorrowpodcast.com 

Subscribe on Spotify, Apple, and YouTube for more stories from the edge of what is possible.

Are large language models like ChatGPT and Claude enough to create AGI?In this clip, Ben Goertzel explains why today’s LLMs are incredibly powerful, but still fundamentally different from true artificial general intelligence.He argues that simply building a bigger version of ChatGPT or Claude is unlikely to produce human-level AGI. Instead, reaching AGI will require new AI architectures that can go beyond their training, generalize to unfamiliar problems and make genuinely novel leaps in reasoning.Ben also explains why current models can already outperform humans in areas like coding, mathematics and knowledge retrieval, while still struggling with the kind of imagination and general intelligence humans use to push beyond existing knowledge.

Full episode here: https://open.spotify.com/episode/7wGN1x0vQQgdzoktHipqBK?si=454702357d55415e

How close are we to AGI?

This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow

The race toward AGI is entering a new phase. Ben Goertzel explores alternative paths to intelligence beyond simply building bigger models.

The conversation also examines the global AI race. The U.S. and China are competing for technological leadership. But the future of AI may not remain centralized.

Then comes the bigger question: what happens after superintelligence? Goertzel imagines AI that could protect humanity. It could even help overcome aging, disease, and other human limitations.

Ben Goertzel is an AI researcher, futurist, and CEO of SingularityNET and BGI Labs. Widely recognized as one of the pioneers of Artificial General Intelligence, he has spent more than two decades developing decentralized AI systems designed to benefit humanity.

What You’ll Learn
Why the AI revolution may be bigger than previous technological shifts

How AI could become an extension of human intelligence

Why agency may matter more than machine consciousness

How the brain creates a simulated model of reality

Whether consciousness could emerge on different substrates

Why AI alignment is also a problem of human alignment

How AI could help humanity become smarter and more coherent

⏱ Timestamps
00:00 Intro
00:07 What Happens in the Next 12 Months?
03:41 Why China Is Catching Up
07:36 Why China Wants AI Control
10:18 Can Governments Control AI?
13:02 Human-Level AGI vs Superintelligence
15:35 Will ASI be Chinese or American?
17:47 The Next Breakthrough to AGI
21:05 How AI Could Become More Intelligent
22:23 Why Language Powers AI
27:33 Can Decentralized AI Change Everything?
32:23 The Global Race vs Decentralized AI
36:22 Would Superintelligence Protect Humanity?
40:19 Can We Build Compassionate AGI?
46:27 Why AI Arms Races Are Dangerous
51:14 Why Governments Shouldn’t Control AI
53:17 Can the Government Keep Up With AI?
54:00 Will Open AI Challenge Big Tech?
55:12 The Future of Decentralized AI
56:27 Could 2045 Arrive by 2028?

Connect with Ben
Website: https://singularitynet.io/ 
LinkedIn: https://www.linkedin.com/in/bengoertzel 
X: https://x.com/bengoertzel 

Connect with Julian
Instagram: https://www.instagram.com/thebeyondtomorrowpodcast/  
Instagram: https://www.instagram.com/juliankissa/  
LinkedIn: https://uk.linkedin.com/in/julian-issa  
Website: www.beyondtomorrowpodcast.com 
Email: bookings@beyondtomorrowpodcast.com 

Subscribe on Spotify, Apple, and YouTube for more stories from the edge of what is possible.

Ramesh Raskar explains how artificial intelligence is evolving and why the coming phase may be critical for its long-term impact on society. He discusses the role of economic systems in guiding responsible innovation and the importance of moving from simply using AI tools to actively participating in their development and governance.

Watch the full episode here: https://open.spotify.com/episode/5zyaecyejQCgbCQ2t2uTt5?si=faf738a4f4ea4a9d

What if we could add 20 healthy years to human life? 

This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at https://agelessrx.com/.  

That’s the ambitious challenge behind the XPRIZE Healthspan competition, where 20 finalist teams are racing to find breakthroughs that could fundamentally change how we age. Driven by the moonshot vision championed by Peter Diamandis, the goal isn’t simply to live longer, it’s to preserve muscle, cognitive, and immune function as we get older.

In this episode, Jamie Justice takes us on a journey to better understand the XPRIZE competition as we take a closer look at Minicircle (Walter Patterson), Longeveron (Brian Rash), NYC Vita (Miriam Merad), Mitochondrial All Stars (David Brown), AgelessRx (Stefanie Morgan and Anar Isman), Ani.Ai (Bruno Balen), and Goqii (Vishal Gondal), exploring their very different approaches to extending healthy lifespan. From gene therapies and mitochondrial interventions to stem cells, AI-powered discoveries, and personalized health solutions, these teams are pushing longevity science into fascinating and largely uncharted territory.

Dr. Jamie Justice is a geroscience researcher and Executive Vice President of Health at XPRIZE, where she leads the organization’s efforts to accelerate breakthroughs in healthy aging.

⏱ Timestamps
00:00 Intro
00:10 What Is the XPRIZE Competition?
04:09 Why XPRIZE Isn’t a Traditional Funding Program
05:37 The XPRIZE’s Approach to Innovation
08:27 Peter Diamandis on the XPRIZE Winner
08:54 Why the Moonshot Has to Be Daring
10:31 What Makes a Breakthrough Solution?
12:44 The Different XPRIZE Categories
13:54 Can More Teams Still Join?
15:24 Clinical Trials Must Finish by 2029
18:24 The Rise of AI Based Interventions
19:11 Unexpected Approaches to Healthspan
22:07 Minicircle: The Non Viral Plasmid DNA Vector

Minicircle
24:53 Why Minicircle’s Gene Therapy Approach Is Different
25:42 A Simpler Gene Therapy Platform
26:29 Why Plasmid Gene Therapy May Be Safer
28:57 The Challenges of Gene Therapy
30:39 Pushback Against Gene Therapy
33:04 The Future of Gene Therapy
34:18 How Teams Are Adapting
36:17 What It Takes to Reach the 20 Year Goal
37:17 No More New Teams in 2028
38:27 Why Some European Teams Are Struggling
40:56 Could Teams Merge to Move Forward?
42:07 Inside the Biologic Category

Longeveron
42:39 The Next Generation of Biologic Therapies
46:50 What Makes This Team Unique?
47:48 Engineering New Biologic Therapies
53:56 Building a Super Team for Healthspan
Featured Team: Mitochondrial All Stars
57:28 The Role of Mitochondria in Aging
59:27 Specializing in Mitochondrial Health
01:00:48 The Power of a Multi Modal Team

NYC Vita
01:03:11 Combining Different Approaches to Aging
01:06:37 Sharing Data Across Teams
01:08:50 Why Collaboration Could Change the Game
01:13:33 A Novel Drug Target for Aging

AgelessRX
01:14:59 A Strategic Approach to Intervention
01:15:52 Can We Achieve 20 Years of Rejuvenation?
01:17:18 The Chemical Combination
01:22:12 The Science Behind the Approach
01:22:46 The Potential of NAD+
01:23:58 Why Japanese Teams Stand Out
01:26:18 The $100 Million Incentive
01:28:10 Inside the Drug Category
01:31:57 Can We Add Healthy Life in One Year?

Ani.Ai 
01:32:49 Healthy Life in Just One Year
01:33:22 The Antibiome Approach
01:36:52 What the Future of Healthspan Could Look Like
01:38:37 The Best Piece of Advice

Connect with Jamie
Website: https://www.xprize.org/ 
Instagram: https://www.instagram.com/j.n.justice/ 
LinkedIn: https://www.linkedin.com/in/jamie-justice-ph-d-6b933146 
X: https://x.com/j_n_justice  
The Teams:
Minicircle: https://minicircle.io/
Longeveron: https://longeveron.com/ 
NYC Vita: https://www.mountsinai.org/ 
AgelessRX: https://agelessrx.com/ 
Ani.Ai: https://www.ani.ai/ 
Goqii: https://goqii.com/us-en